1. MCL‐R2 ELDERLY: A PHASE III STUDY OF THE EUROPEAN MCL NETWORK ASSESSING EFFICACY OF ALTERNATING IMMUNOCHEMOTHERAPY (R‐CHOP / R‐HAD) AND a RITUXIMAB‐LENALIDOMIDE MAINTENANCE. (June 2017) Authors: Ribrag, V.; Feugier, P.; Doorduijn, J.; Delfau‐Larue, M.; Hermine, O.; Kluin‐Nelemans, H.; Dasilva, M.; Lopez‐Hernandez, A.; Walewski, J.; Szymczyk, M.; Pott, C.; Homburg, C.; Van der Velden, V.; Gameiro, P.; Garcia‐Sanz, R.; Ladetto, M.; van Krieken, H.; Cabeçadas, J.; Rymkiewicz, G.; Klapper, W. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗